About OraSure Technologies, Inc. 
OraSure Technologies, Inc.
Pharmaceuticals & Biotechnology
OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.
Company Coordinates 
Company Details
150 WEBSTER ST , BETHLEHEM PA : 18015
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 64 Schemes (42.13%)
Foreign Institutions
Held by 106 Foreign Institutions (10.26%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Michael Celano
Independent Chairman of the Board
Dr. Stephen Tang
President, Chief Executive Officer, Director
Lelio Marmora
Director
Ms. Mara Aspinall
Independent Director
Mr. James Datin
Independent Director
Mr. Eamonn Hobbs
Independent Director
Mr. Ronny Lancaster
Independent Director
Revenue and Profits:
Net Sales:
31 Million
(Quarterly Results - Jun 2025)
Net Profit:
-20 Million
Pharmaceuticals & Biotechnology
USD 238 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.61
-12.77%
0.62






